Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity

被引:11
作者
Roque, Catarina [1 ]
Santos, Francisco Sousa [1 ]
Pilli, Tania [2 ]
Dalmazio, Gilda [2 ]
Castagna, Maria Grazia [2 ]
Pacini, Furio [2 ]
机构
[1] Occident Hosp Ctr Lisbon, Dept Internal Med, Sect Endocrinol Diabet & Metab, Egas Moniz Hosp, P-1349019 Lisbon, Portugal
[2] Univ Siena, Dept Med & Surg Sci & Neurosci, Sect Endocrinol, Siena, Italy
关键词
toxic multinodular goiter; hyperthyroidism; radioiodine; fixed activity; 15; mCi; volume reduction; RADIOACTIVE IODINE; NODULAR GOITER; FOLLOW-UP; I-131; TREATMENT; GRAVES-DISEASE; THERAPY; HYPERTHYROIDISM; HYPOTHYROIDISM; ANTIBODIES; EFFICIENCY;
D O I
10.1210/clinem/dgaa214
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Long-term studies evaluating the treatment of toxic multinodular goiter (TMNG) with fixed activities of radioiodine (RAI) are lacking. Objective: The objective of this work is to describe the effects of 15 mCi on thyroid volume, function, and autoimmunity in the long term. Design and Setting: A population-based, retrospective analysis with up to 12 years of followup was conducted in Siena, Italy. Participants: Adult patients (n = 153) with TMNG, naive to RAI, were included. Methods: Evaluation was performed of thyroid function, antithyroid antibodies, and ultrasound scans before and yearly after RAI. Main Outcome Measures: Evaluations included hyperthyroidism cure, hypothyroidism, volume reduction, nadir and regain, and antibody titer change. Results: The study revealed mean volume reductions greater than or equal to 50% at 3 years after RAI; the greatest annual reduction was observed during the first year (30 +/- 17.8%; P < .001). Most patients (60%) achieved their volume nadir 3 to 6 years after RAI. Although 22% patients showed volume regain, the net reduction was statistically significant as late as 9 years after RAI (P = .005). The mean time to hypothyroidism was 2.7 +/- 2.4 years, and it was associated with greater reductions in volume (P = .01). During the first 3 years after treatment, hyperthyroid patients decreased approximately by 50% per year without additional RAI. There was no statistically significant association of antibody titers with thyroid function except for antithyrotropin receptor antibodies and hyperthyroidism (P = .004). At the end of follow-up there were 61.6% euthyroid patients, 11% hyperthyroid (4.8% overt), and 27.4% hypothyroid patients (2.7% overt). Hyperthyroidism was cured in 89%. Conclusions: The treatment of TMNG with 15 mCi of RAI induced low hypothyroidism rates while providing high cure rates and significant volume reduction, which was maintained in the long term.
引用
收藏
页码:E2464 / E2470
页数:7
相关论文
共 32 条
[1]   The occurrence of hypothyroidism following radioactive iodine treatment of toxic nodular goiter is related to the TSH level [J].
Adamali, H. I. ;
Gibney, J. ;
O'Shea, D. ;
Casey, M. ;
McKenna, T. J. .
IRISH JOURNAL OF MEDICAL SCIENCE, 2007, 176 (03) :199-203
[2]   Long-Term Results of Fixed High-Dose I-131 Treatment for Toxic Nodular Goiter: Higher Euthyroidism Rates in Geriatric Patients [J].
Aktas, Gul Ege ;
Turoglu, Halil Turgut ;
Erdil, Tanju Yusuf ;
Inanir, Sabahat ;
Dede, Fuat .
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2015, 24 (03) :94-99
[3]   Radioiodine treatment of hyperthyroidism - Prognostic factors for outcome [J].
Allahabadia, A ;
Daykin, J ;
Sheppard, MC ;
Gough, SCL ;
Franklyn, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3611-3617
[4]   Radioiodine therapy for thyroid volume reduction of large goitres [J].
Bachmann, Juliane ;
Kobe, Carsten ;
Bor, Seher ;
Rahlff, Ilka ;
Dietlein, Markus ;
Schicha, Harald ;
Schmidt, Matthias .
NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (06) :466-471
[5]   The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter:: Effect on thyroid function and size and pulmonary function [J].
Bonnema, SJ ;
Bertelsen, H ;
Mortensen, J ;
Andersen, PB ;
Knudsen, DU ;
Bastholt, L ;
Hegedüs, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3636-3641
[6]   Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome [J].
Bonnema, Steen Joop ;
Hegedus, Laszlo .
ENDOCRINE REVIEWS, 2012, 33 (06) :920-980
[7]   Outcome of thyroid function in Graves' patients treated with radioiodine: Role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage [J].
Chiovato, L ;
Fiore, E ;
Vitti, P ;
Rocchi, R ;
Rago, T ;
Dokic, D ;
Latrofa, F ;
Mammoli, C ;
Lippi, F ;
Ceccarelli, C ;
Pinchera, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01) :40-46
[8]   Relapses of hypertroidism in patients treated with a radioiodine for nodular toxic goiter: Relation to thyroid autoimmunity [J].
Custro, N ;
Ganci, A ;
Scafidi, V .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2003, 26 (02) :106-110
[9]  
DANACI M, 1988, NEW ZEAL MED J, V101, P784
[10]   Efficiency of radioactive I-131 therapy in geriatric patients with toxic nodular goiter [J].
Erkan, Melih Engin ;
Demirin, Hilmi ;
Asik, Muhammed ;
Celbek, Gokhan ;
Yildirim, Mustafa ;
Aydin, Yusuf ;
Gungor, Adem ;
Dogan, Ahmet Semih .
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 24 (06) :714-717